1. Home
  2. PRTA vs HY Comparison

PRTA vs HY Comparison

Compare PRTA & HY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • HY
  • Stock Information
  • Founded
  • PRTA 2012
  • HY 1991
  • Country
  • PRTA Ireland
  • HY United States
  • Employees
  • PRTA N/A
  • HY N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • HY Construction/Ag Equipment/Trucks
  • Sector
  • PRTA Health Care
  • HY Industrials
  • Exchange
  • PRTA Nasdaq
  • HY Nasdaq
  • Market Cap
  • PRTA 1.2B
  • HY 1.3B
  • IPO Year
  • PRTA N/A
  • HY N/A
  • Fundamental
  • Price
  • PRTA $21.89
  • HY $59.33
  • Analyst Decision
  • PRTA Buy
  • HY Strong Buy
  • Analyst Count
  • PRTA 7
  • HY 2
  • Target Price
  • PRTA $58.83
  • HY $87.00
  • AVG Volume (30 Days)
  • PRTA 255.3K
  • HY 64.9K
  • Earning Date
  • PRTA 10-31-2024
  • HY 10-29-2024
  • Dividend Yield
  • PRTA N/A
  • HY 2.35%
  • EPS Growth
  • PRTA N/A
  • HY 384.84
  • EPS
  • PRTA N/A
  • HY 10.00
  • Revenue
  • PRTA $217,246,000.00
  • HY $4,253,000,000.00
  • Revenue This Year
  • PRTA $59.66
  • HY $7.25
  • Revenue Next Year
  • PRTA N/A
  • HY N/A
  • P/E Ratio
  • PRTA N/A
  • HY $5.97
  • Revenue Growth
  • PRTA 276.98
  • HY 8.63
  • 52 Week Low
  • PRTA $18.69
  • HY $38.50
  • 52 Week High
  • PRTA $55.89
  • HY $84.44
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 58.55
  • HY 45.13
  • Support Level
  • PRTA $20.15
  • HY $55.67
  • Resistance Level
  • PRTA $22.83
  • HY $58.99
  • Average True Range (ATR)
  • PRTA 0.82
  • HY 1.76
  • MACD
  • PRTA 0.13
  • HY 0.23
  • Stochastic Oscillator
  • PRTA 82.66
  • HY 52.83

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About HY Hyster-Yale Materials Handling Inc.

Hyster-Yale Materials Handling Inc designs, engineers, manufactures, sells, and services a line of lift trucks and aftermarket parts. It manufactures components, such as frames, masts, and transmissions; and assembles lift trucks and the products are market under the Hyster and Yale brand names to independent Hyster and Yale retail dealerships. The company operates through three geographical regions namely: the Americas, EMEA, JAPIC, of which Americas accounts for the larger share of the revenue.

Share on Social Networks: